Clinical Chem Enzymology
To understand the clinically important enzymes and isoenzymes, as well as their changes in certain disorders.
Biological catalyst that increases the rate of a biochemical reaction
catalyses the conversion of substrates → products
specific
Not undergoing permanent changes or being consumed
Alter the rate, NOT the equilibrium point
Most are proteins or conjugated proteins
primary structure - linear sequence of the amino acids
secondary structure - three-dimensionally coiled polypeptides
tertiary structure - subsequent folding of secondary structure
Active site
interaction and binding site for substrate
a cleft or groove formed by the specific folding pattern of specific amino acid residues
determines substrate specificity
optimal temperature for most enzymes: below 40C
doubling of enzymatic activity with an increase of 10C
change in pH affects the ionisation state of acidic or basic amino acids
change the structure and shape of enzyme → affect/inactivate enzyme activity
each enzyme has an optimal pH value, ranging from pH 1.5-8.0
↑enzyme concentration
↑ active sites to convert substrate molecules into products
needs to have an excess of substrate
zero-order kinetics
a reaction under the condition of substrate excess
all active sites of enzymes are saturated in an excess of substrate
rate of reaction us independent of substrate concentration
concentration of product formed over a specified period of time depends on the enzyme concentration
↑ substrate concentration, ↑ rate of product formation, at a constant enzyme concentration
rate of product formation is linear & proportional to the substrate concentration, until a limiting point is reached
limiting point
all active sites are occupied with substrates
rate of reaction at its maximum
further increase in the substrate concentration does not increase the reaction rate
Name if the substrate/group targeted by the enzyme, followed by the suffix -ase
e.g., urease → enzyme that hydrolyses urea
Name indicated the reaction catalysed by the enzyme
e.g., glucose oxidase enzyme that catalyses the oxidation of glucose to gluconolactone & hydrogen peroxidase
Empirical name, e.g., trypsin & pepsin
Membrane-bound glycoprotein on the outer layer of cell membrane
exists as a group of isoenzymes in different tissue sites
found on membranes and cell surfaces of small intestine, kidneys, liver, bone & placenta
majority (>80%) of alkaline phosphatase in serum is liver isoenzyme, followed by the bone isoenzyme & a small amount from intestine
Physiological functions:
catalyses the hydrolysis of phosphate monoesters at alkaline pH
releases inorganic phosphate from the substrate
requires divalent cations as cofactors
only found in the tissues under normal physiological condition
increased production under specific condition may release it into circulation
significantly increased activity in obstructive hepatobiliary disease & osteoblast-mediated bone disease
elevated serum alkaline phosphatase level
biliary tract obstruction: 3-10x the upper limit of reference interval
hepatobiliary disorders: alkaline phosphatase + other markers of hepatic function
elevated serum level is common in osteoblast-related disorders
primary or metastatic cancer with local bile duct obstruction & increasing leakage of liver isoenzyme
elevated serum level starting 16 weeks of gestation
2-3x the upper limit of the reference interval in third trimester
less common
hypophosphatasia, postmenopausal women receiving oestrogen therapy for osteoporosis, Wilson’s disease, magnesium deficiency, hypothyroidism & severe anaemia
An oxidoreductase important in anaerobic metabolic pathway
present in almost all tissue, but significant level in heart, skeletal muscle, liver & kidneys
higher concentration in the cytoplasm than serum
tetramers of either of the 2 types of subunits:
muscle (M)
heart (H)
Exhibits 5 isomeric forms:
LDH1 - 4 heart subunits; heart tissue
LDH2 - 3 heart & 1 muscle subunits; reticuloendothelial system
LDH3 - 2 heart and 2 muscle subunits; lungs
LDH4 - 1 heart and 3 muscle subunits; kidneys
LDH5 - 4 muscle subunits; liver & skeletal muscle
Physiological functions:
involved in the anaerobic metabolism of glucose when there is an absence or limited supply of oxygen in tissues
catalyses the reversible conversion of pyruvate to lactate, with the use of NADH
lactate is transported to the liver
reversibly converting lactate to pyruvate
Clinical relevance:
slight to moderate elevation: acute myocardial infarction, pulmonary embolism, leukaemia, haemolytic anaemia, liver & renal disease
significantly elevated: pernicious anaemia, megaloblastic anaemia, certain cancers
To understand the clinically important enzymes and isoenzymes, as well as their changes in certain disorders.
Biological catalyst that increases the rate of a biochemical reaction
catalyses the conversion of substrates → products
specific
Not undergoing permanent changes or being consumed
Alter the rate, NOT the equilibrium point
Most are proteins or conjugated proteins
primary structure - linear sequence of the amino acids
secondary structure - three-dimensionally coiled polypeptides
tertiary structure - subsequent folding of secondary structure
Active site
interaction and binding site for substrate
a cleft or groove formed by the specific folding pattern of specific amino acid residues
determines substrate specificity
optimal temperature for most enzymes: below 40C
doubling of enzymatic activity with an increase of 10C
change in pH affects the ionisation state of acidic or basic amino acids
change the structure and shape of enzyme → affect/inactivate enzyme activity
each enzyme has an optimal pH value, ranging from pH 1.5-8.0
↑enzyme concentration
↑ active sites to convert substrate molecules into products
needs to have an excess of substrate
zero-order kinetics
a reaction under the condition of substrate excess
all active sites of enzymes are saturated in an excess of substrate
rate of reaction us independent of substrate concentration
concentration of product formed over a specified period of time depends on the enzyme concentration
↑ substrate concentration, ↑ rate of product formation, at a constant enzyme concentration
rate of product formation is linear & proportional to the substrate concentration, until a limiting point is reached
limiting point
all active sites are occupied with substrates
rate of reaction at its maximum
further increase in the substrate concentration does not increase the reaction rate
Name if the substrate/group targeted by the enzyme, followed by the suffix -ase
e.g., urease → enzyme that hydrolyses urea
Name indicated the reaction catalysed by the enzyme
e.g., glucose oxidase enzyme that catalyses the oxidation of glucose to gluconolactone & hydrogen peroxidase
Empirical name, e.g., trypsin & pepsin
Membrane-bound glycoprotein on the outer layer of cell membrane
exists as a group of isoenzymes in different tissue sites
found on membranes and cell surfaces of small intestine, kidneys, liver, bone & placenta
majority (>80%) of alkaline phosphatase in serum is liver isoenzyme, followed by the bone isoenzyme & a small amount from intestine
Physiological functions:
catalyses the hydrolysis of phosphate monoesters at alkaline pH
releases inorganic phosphate from the substrate
requires divalent cations as cofactors
only found in the tissues under normal physiological condition
increased production under specific condition may release it into circulation
significantly increased activity in obstructive hepatobiliary disease & osteoblast-mediated bone disease
elevated serum alkaline phosphatase level
biliary tract obstruction: 3-10x the upper limit of reference interval
hepatobiliary disorders: alkaline phosphatase + other markers of hepatic function
elevated serum level is common in osteoblast-related disorders
primary or metastatic cancer with local bile duct obstruction & increasing leakage of liver isoenzyme
elevated serum level starting 16 weeks of gestation
2-3x the upper limit of the reference interval in third trimester
less common
hypophosphatasia, postmenopausal women receiving oestrogen therapy for osteoporosis, Wilson’s disease, magnesium deficiency, hypothyroidism & severe anaemia
An oxidoreductase important in anaerobic metabolic pathway
present in almost all tissue, but significant level in heart, skeletal muscle, liver & kidneys
higher concentration in the cytoplasm than serum
tetramers of either of the 2 types of subunits:
muscle (M)
heart (H)
Exhibits 5 isomeric forms:
LDH1 - 4 heart subunits; heart tissue
LDH2 - 3 heart & 1 muscle subunits; reticuloendothelial system
LDH3 - 2 heart and 2 muscle subunits; lungs
LDH4 - 1 heart and 3 muscle subunits; kidneys
LDH5 - 4 muscle subunits; liver & skeletal muscle
Physiological functions:
involved in the anaerobic metabolism of glucose when there is an absence or limited supply of oxygen in tissues
catalyses the reversible conversion of pyruvate to lactate, with the use of NADH
lactate is transported to the liver
reversibly converting lactate to pyruvate
Clinical relevance:
slight to moderate elevation: acute myocardial infarction, pulmonary embolism, leukaemia, haemolytic anaemia, liver & renal disease
significantly elevated: pernicious anaemia, megaloblastic anaemia, certain cancers